The US Department of Health and Human Services (HHS) recently issued the first Project BioShield contract to fund research to support the use of an existing antibiotic to treat inhalational anthrax exposure.
Former President George W. Bush signed the Project BioShield Act in 2004 to accelerate research, development, purchase, and availability of medical countermeasures against chemical, biological, radiological, and nuclear agents.
Rubin R. HHS Funds Development of Antibiotic to Treat Anthrax. JAMA. 2020;323(8):700. doi:10.1001/jama.2020.1004
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.